Casirivimab + Imdevimab

Introduction

Casirivimab + Imdevimab is a combination of two monoclonal antibodies used to help fight viral infections like COVID-19. These antibodies are designed to target the virus and stop it from multiplying inside the body. This medicine is generally given to patients who have mild to moderate symptoms and are at high risk of developing severe disease. It helps in reducing the chances of hospitalization and serious complications. Casirivimab + Imdevimab is usually administered in a hospital or clinical setting under medical supervision for better safety and monitoring.

Uses of Casirivimab + Imdevimab

• Treatment of mild to moderate COVID-19 infection
• Helps prevent worsening of COVID-19 symptoms
• Reduces the risk of hospitalization in high-risk patients
• Used for patients with weak immunity or multiple health issues

How Casirivimab + Imdevimab works

Casirivimab and Imdevimab are monoclonal antibodies that work by attaching to the spike protein of the SARS-CoV-2 virus. This blocks the virus from entering human cells and prevents it from multiplying. By reducing the viral load, it helps the immune system control the infection better. This action lowers the chances of severe illness and speeds up recovery when given at the right time, especially in high-risk patients.

Benefits of Casirivimab + Imdevimab

• Helps control COVID-19 infection early
• Reduces risk of severe complications
• Lowers chances of hospitalization
• Supports faster recovery in eligible patients
• Useful for high-risk groups such as elderly and immunocompromised patients

How to take Casirivimab + Imdevimab

Casirivimab + Imdevimab is given only under medical supervision. It may be administered as an intravenous infusion (IV drip) or injection as prescribed by the doctor. The dosage depends on the patient’s condition, body weight, and severity of infection. This medicine should be taken as soon as possible after COVID-19 diagnosis or exposure (as advised). Do not self-administer this medicine at home. After administration, the patient may be monitored for some time to check for allergic reactions or side effects.

Type of Dosage Available

• Injection
• Intravenous infusion (IV)

Side effects of Casirivimab + Imdevimab

• Fever
• Chills
• Nausea
• Headache
• Dizziness
• Itching or rash
• Injection site pain or swelling
• Breathing difficulty (rare but serious)
• Severe allergic reaction/anaphylaxis (rare)

Safety advice

• Pregnancy: Use only if prescribed by doctor. Inform your doctor if you are pregnant or planning pregnancy.
• Breastfeeding: Consult doctor before use, as safety information may be limited.
• Allergy: Do not use if you are allergic to Casirivimab, Imdevimab, or any ingredient.
• Medical history: Tell your doctor about immune disorders, chronic disease, or ongoing medications.
• Monitoring: Patient monitoring is recommended after administration to manage any reaction.
• Driving: Avoid driving if you feel dizziness or weakness after taking this medicine.
• Vaccination: Inform your doctor if you have taken or plan to take COVID vaccine.

Frequently Asked Questions (FAQs)

Q. What is Casirivimab + Imdevimab used for?
A: Casirivimab + Imdevimab is mainly used for the treatment of mild to moderate COVID-19 in patients who are at high risk of severe infection.

Q. Is Casirivimab + Imdevimab an antibiotic?
A: No, it is not an antibiotic. It is a combination of monoclonal antibodies that target the virus and help stop its spread in the body.

Q. How is Casirivimab + Imdevimab given?
A: It is given by injection or IV infusion under doctor supervision in a hospital or clinical setup.

Q. Can Casirivimab + Imdevimab be used at home?
A: No, it should not be used at home. It must be administered by a healthcare professional.

Q. What are the common side effects of Casirivimab + Imdevimab?
A: Common side effects include fever, nausea, headache, dizziness, rash, and injection site reactions.